EcoDrugPlus

Integrin Alpha-5-Like

Ensembl ID : ENSSTUG00000030861
Gene Symbol: LOC115167991
3 Cross references
200 Possible Orthologues:

Integrin Alpha-Iib-Like

Ensembl ID : ENSSTUG00000007596
Gene Symbol: LOC115196399
3 Cross references
183 Possible Orthologues:

Integrin Alpha-Iib-Like

Ensembl ID : ENSSTUG00000036682
Gene Symbol: LOC115170938
3 Cross references
183 Possible Orthologues:

Integrin Beta-1-Like

Ensembl ID : ENSSTUG00000020085
Gene Symbol: LOC115195888
3 Cross references
209 Possible Orthologues:

Integrin Beta-3-Like

Ensembl ID : ENSSTUG00000006028
Gene Symbol: LOC115197615
3 Cross references
195 Possible Orthologues:

Integrin Beta-3-Like

Ensembl ID : ENSSTUG00000020581
Gene Symbol: LOC115161137
3 Cross references
194 Possible Orthologues:

Integrin Beta-3-Like

Ensembl ID : ENSSTUG00000030622
Gene Symbol: LOC115171083
3 Cross references
195 Possible Orthologues:

Integrin Beta-5-Like

Ensembl ID : ENSSTUG00000021179
Gene Symbol: LOC115160928
3 Cross references
204 Possible Orthologues:

Integrin Beta-5-Like

Ensembl ID : ENSSTUG00000038146
Gene Symbol: LOC115155594
3 Cross references
204 Possible Orthologues:

Integrin Beta-7-Like

Ensembl ID : ENSSTUG00000012421
Gene Symbol: LOC115150589
2 Cross references
145 Possible Orthologues:

Integrin Beta-7-Like

Ensembl ID : ENSSTUG00000006070
Gene Symbol: LOC115165442
2 Cross references
133 Possible Orthologues:

Integrin Beta-7-Like

Ensembl ID : ENSSTUG00000014403
Gene Symbol: LOC115207816
2 Cross references
144 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).